IMPACT OF CONCOMITANT THIOPURINE ON THE EFFICACY AND SAFETY OF FILGOTINIB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Kenji Watanabe  1     Laurent Peyrin-Biroulet  2     Silvio Danese  3     Kahaku Emoto  4     Yasushi Fujitani  4     Franck-Olivier Le-Brun  5     Alessandra Oortwijn  6     Tomohiro Ueno  4     James O. Lindsay  7     Gerhard Rogler  8     Toshifumi Hibi  9    
1 Center for Inflammatory Bowel Disease, Division of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
2 University Hospital of Nancy, University of Lorraine, Nancy, France
3 IBD Center, Humanitas Research Hospital, Milan, Italy
4 Gilead Sciences K.K., Tokyo, Japan
5 Galapagos GmbH, Basel, Switzerland
6 Galapagos NV, Leiden, Netherlands
7 Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom
8 University Hospital of Zurich, University of Zurich, Zurich, Switzerland
9 Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing